ArticleOncotarget2016

The feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDG.

Yanfen Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.